HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 17,420
+490 (2.89%)
Apr 10, 2026, 3:30 PM KST
-4.55% (1Y)
| Market Cap | 244.62B -29.5% |
| Revenue (ttm) | 205.58B +469.5% |
| Net Income | 4.57B +867.2% |
| EPS | 140.00 +310.2% |
| Shares Out | 14.04M |
| PE Ratio | 124.43 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 144,425 |
| Average Volume | 141,354 |
| Open | 17,150 |
| Previous Close | 16,930 |
| Day's Range | 16,870 - 17,470 |
| 52-Week Range | 12,500 - 22,250 |
| Beta | 0.39 |
| RSI | 61.49 |
| Earnings Date | May 15, 2026 |